<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>H. Eby | CDRL</title>
    <link>https://www.cdrl-ut.com/authors/h.-eby/</link>
      <atom:link href="https://www.cdrl-ut.com/authors/h.-eby/index.xml" rel="self" type="application/rss+xml" />
    <description>H. Eby</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Fri, 26 Feb 2021 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://www.cdrl-ut.com/img/icon-192.png</url>
      <title>H. Eby</title>
      <link>https://www.cdrl-ut.com/authors/h.-eby/</link>
    </image>
    
    <item>
      <title>Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach</title>
      <link>https://www.cdrl-ut.com/publication/2021-02-26_rn5133/</link>
      <pubDate>Fri, 26 Feb 2021 00:00:00 +0000</pubDate>
      <guid>https://www.cdrl-ut.com/publication/2021-02-26_rn5133/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Oxytocin&#39;s anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach</title>
      <link>https://www.cdrl-ut.com/publication/2020-08-19_rn5141/</link>
      <pubDate>Wed, 19 Aug 2020 00:00:00 +0000</pubDate>
      <guid>https://www.cdrl-ut.com/publication/2020-08-19_rn5141/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS</title>
      <link>https://www.cdrl-ut.com/publication/2020-07-24_rn5144/</link>
      <pubDate>Fri, 24 Jul 2020 00:00:00 +0000</pubDate>
      <guid>https://www.cdrl-ut.com/publication/2020-07-24_rn5144/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
